Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.

Google Scholar
  • 1 May 2002
    • journal article
    • editorial
    • Vol. 8 (5), 962-6
Abstract
No abstract available